Theragen Etex Co (XKRX:066700) Short-Term Capital Lease Obligation : ₩626 Mil (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Theragen Etex Co Short-Term Capital Lease Obligation?

Theragen Etex Co's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ₩626 Mil.

Theragen Etex Co's quarterly Short-Term Capital Lease Obligation declined from Sep. 2024 (₩851 Mil) to Dec. 2024 (₩738 Mil) and declined from Dec. 2024 (₩738 Mil) to Mar. 2025 (₩626 Mil).

Theragen Etex Co's annual Short-Term Capital Lease Obligation declined from Dec. 2022 (₩1,159 Mil) to Dec. 2023 (₩1,026 Mil) and declined from Dec. 2023 (₩1,026 Mil) to Dec. 2024 (₩738 Mil).

Theragen Etex Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for Theragen Etex Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theragen Etex Co Short-Term Capital Lease Obligation Chart

Theragen Etex Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

809.77

1,175.22

1,159.05

1,026.11

737.64

Theragen Etex Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															928.49	779.93	851.04	737.64	626.19

Theragen Etex Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Theragen Etex Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Theragen Etex Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Theragen Etex Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Theragen Etex Co Ltd (XKRX:066700) » Definitions » Short-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

58, Sandan-ro 68-gil, Danwon-gu, Gyeonggi-do, Ansan-si, KOR

Website

http://www.theragenetex.com

Theragen Etex Co Ltd is a Korea-based company mainly engaged in the manufacturing and selling of finished pharmaceutical products and providing genome sequencing services. It also provides healthcare services. The company's operating segments include its Pharmaceutical business and the Healthcare and Genome Analysis Business. A majority of its revenue is generated from the Pharmaceutical Business which involves the manufacturing and sales of specialized and general medicine along with new drug research and development. The Healthcare and Genome Analysis Business involves DNA sequence analysis, RNA mutation genome analysis and decoding, and the distribution of non-prescription drugs for healthcare purposes. Geographically, the company derives its key revenue from the domestic market.

Theragen Etex Co Headlines

No Headlines